Back to Top Skip to main content

Defending the Homeland: NMRTC Bremerton ensures Operational Readiness and a Medically Ready Force

Three healthcare workers wearing masks Rear Adm. Blake L. Converse, Commander, Submarine Force, U.S. Pacific Fleet, recently contacted Capt. Shannon J. Johnson, Commanding Officer, Navy Medicine Readiness and Training Command (NMRTC) Bremerton, on behalf of his submariners, thanking her command’s leadership and Sailors for their support to the Pacific Submarine Force during the COVID-19 pandemic outbreak. (Official Navy photo by Douglas H Stutz, NMRTC Bremerton public affairs officer)

Recommended Content:

Coronavirus | Health Readiness

‘Swabbie’ might be older generational slang for a Sailor, but current Navy Medicine swab testing support for the Fleet has been timely, as well as progressive.

Navy Rear Adm. Blake Converse, commander, Submarine Force, U.S. Pacific Fleet, recently contacted Navy Capt. Shannon Johnson, commanding officer, Navy Medicine Readiness and Training Command Bremerton, on behalf of his submariners, thanking her command’s leadership and Sailors for their support to the Pacific Submarine Force during the COVID-19 pandemic outbreak.

“Through these uncertain times, your team took care of my Sailors in a disciplined yet compassionate manner,” wrote Converse. “It is clear that NMRTC Bremerton has every Sailor in their best interest. Your efforts contribute to the submarine force’s mission readiness.”

Supporting mission readiness has long been a responsibility for the ready medical force of NMRTC Bremerton, ensuring that Navy ship, squadron, shore and submarine personnel are collectively a medically ready force and operationally fit to perform and deploy when called upon.

According to Navy Cmdr. Robert Uniszkiewicz, NHB/NMRTC Bremerton COVID-19 lead and Public Health Emergency Officer, the effectiveness of  the swab testing for the submarine fleet homeported in the Pacific Northwest is a direct extension of the protective measures implemented at all commands to help curtail the spread of COVID-19.

Image of Hannah Carlson wearing a mask
Navy Hospital Corpsman 1st Class Hannah Carlson, assigned to Naval Hospital Bremerton's Urgent Care Clinic, oversees daily clinical duties during the command's ongoing effort to help stop the spread of COVID-19. Carlson's efforts the past months have her highly regarded as the linchpin for the UCC.  (Official Navy photo by Douglas H Stutz, NHB/NMRTC Bremerton public affairs officer)

“Testing is not as important as physical distancing, wearing facial coverings and proper hygiene practices, explained Uniszkiewicz. “However, with these measures in place, large scale surveillance testing has provided another layer of confidence that our units preparing to deploy are both ready and safe to do so.”

The swab testing itself is unique simply because having a foreign object inserted into the nasal passage is not a common experience. The hospital corpsman inserts the swab – similar to a longer version of a Q-tip – deep into a person’s nose where it is whirled around for several seconds to collect secretion sample necessary for testing.

Taking the sample is just the initial step. Uniszkiewicz noted that NMRTC Bremerton has not been alone in the task of ensuring units are ready to deploy. It’s been a team-effort across the board with a number of support layers in place.

“Our testing efforts would not be possible without the collaboration with Madigan Army Medical Center laboratory. Additionally, serviced commands are stepping up by conducting their own contact tracing for which our Preventive Medicine team has conducted training. For large scale testing, it has been a tri-service effort to meet the demands for supply, transport, and tracking in order to preserve (COVID-free) ‘bubbles’ around units before deployment, during deployment, and after deployment when they return,” explained Uniszkiewicz.

At NMRTC Bremerton, there are noticeable safeguards added, e.g., waiting room seating has been changed to be six feet apart and areas to stand are also marked six feet apart. Per Department of Defense directive, it is also mandatory for all staff, patients and visitors to wear either a facial covering or mask. Only one visitor is allowed per patient and frequent cleaning of ‘high touch’ areas is now standard procedure, even more so that in the past. Although non-urgent surgeries have resumed and face-to-face encounters have gradually increased, virtual appointments are continuing to be offered.

Screening and testing protocol is also in place for all those eligible for care at NMRTC Bremerton.

“Screening upon entry to the facility is an invaluable mitigation strategy to keep COVID-like illness out of the hospital proper and direct it toward our Urgent Care Center and tents.  This, along with universal use of facial coverings, reassures our patients, their families, and our staff that we are dedicated to keeping them as safe as possible within our facilities,” Uniszkiewicz said.

The screening process really begins prior to an appointment as patients are contacted for pre-screening checks. Once a person arrives at the command, there are staff directing traffic flow to guide them. They are directed through the screening process which begins with a series of questions. Depending on the replies, the patient will be directed to either a treatment tent or testing area, or given the ‘green light’ to enter the hospital following the protective measures in place.

Additionally, before entering the hospital or clinic, if a person does not have a facial covering, they will be provided one to wear at all times when in the hospital.

At NHB/NMRTC Bremerton and across the Navy, medical providers and staff are ensuring patients are properly cared for in the COVID-19 environment, while still maintaining operational readiness.

You also may be interested in...

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA IPM 19-003: Reserve Health Readiness Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i): • Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements. • Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command). • Communicate procedure guidance to all DoD organizations utilizing RHRP services. • Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.

  • Identification #: 19-003
  • Date: 3/8/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Health Readiness

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

  • Identification #: DHA PI 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Policy

Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

DoD Laboratories Participating in CDC Laboratory Response Network 03-213

Policy

Department of Defense (DoD) laboratories participating in the Centers for Disease Control and Prevention-sponsored Laboratory Response Network (LRN) do so with the approval and support of their respective Military Department Surgeons General.

  • Identification #: 03-213
  • Date: 3/26/2013
  • Type: Memorandums
  • Topics: Health Readiness

Medical Planning and Programming Lexicon

Policy

DoD Instruction Number 6490.11: DoD Policy Guidance for Management of Mild Traumatic Brain Injury/Concussion in the Deployed Setting

Policy

This instruction establishes policy, assigns responsibilities, and provides procedures on the management of mild traumatic brain injury (mTBI), also known as concussion, in the deployed setting.

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.